EZ BREATHE ATOMIZER
Report
- Report Number
- 3005442893-2013-00026
- Date Received
- June 7, 2013
- Date of Event
- April 23, 2013
- Report Date
- May 7, 2013
- Manufacturer
- HEALTH & LIFE (SUZHOU) CO., LTD.
- Product Code
- CCQ
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
AN EVAL OF THIS FAILURE MODE FROM THE DESIGN FAILURE MODES AND EFFECTS ANALYSIS OF THIS PRODUCT, THAT THE USE OF THE PRODUCT IN A MANNER LIKELY TO CAUSE ADVERSE HEALTH CONSEQUENCE IS IMPROBABLE AND THAT NO COMPLAINTS DOCUMENTING DEATHS OR SERIOUS INJURIES HAVE BEEN REC'D. HERE WITH THE INVESTIGATION REPORT AS ATTACHMENT, AND THE COMPLAINED DEVICE WAS NOT AVAILABLE FOR FURTHER INVESTIGATION, THEREFORE, THE ROOT CAUSE CANNOT BE IDENTIFIED.
THE CUSTOMER CONTACTED NEPHRON PHARMACEUTICALS CORPORATION REGARDING AN ADVERSE DRUG EXPERIENCE AND PRODUCT COMPLAINT ON (B)(6) 2013. THE PT REPORTED THAT SHE EXPERIENCED JITTERINESS AND HEADACHES DURING THE INITIAL USE OF ASTHMANEFRIN INHALATION SOLUTION VIA THE EZ BREATHE ATOMIZER; HOWEVER, SHE REPORTED THAT HER BREATHING IMPROVED. AFTER THREE USES OF THE PRODUCT, THE CUSTOMER REPORTED THAT THE ATOMIZER WOULD ONLY PRODUCE A SMALL AMOUNT OF AEROSOL. SHE TOOK THE ASTHMANEFRIN AND EZ BREATH ATOMIZER TO HER JOB SINCE SHE WAS HAVING TROUBLE BREATHING. SHE REPORTED THAT THE ATOMIZER WOULD ONLY PRODUCE A SMALL AMOUNT OF MIST, AND THE MIST WAS INSUFFICIENT TO ALLEVIATE HER ASTHMA SYMPTOMS. AS A RESULT OF THE DEVICE'S PERFORMANCE, THE CUSTOMER REPORTED THAT SHE SUFFERED ASTHMA PROBLEMS FROM TUESDAY EVENING UNTIL WEDNESDAY MORNING. AT AROUND 6AM ON WEDNESDAY MORNING, THE CUSTOMER REPORTED THAT SHE WENT TO THE HOSPITAL FOR TREATMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 253558 | EZ BREATHE ATOMIZER | ATOMIZER | CCQ | HEALTH & LIFE (SUZHOU) CO., LTD. | EZ-100 | UNIDENTIFIED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 44 YR | Hospitalization| O | ASTHMANEFRIN INHALATION SOLUTION |